Albert David Ltd (ALBERTDAVD) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 876497,
    "name": "Albert David",
    "stock_name": "Albert David",
    "full_name": "Albert David Ltd",
    "name_url": "stocks-analysis/albert-david",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "816.70",
    "chg": 92.85,
    "chgp": "12.83%",
    "dir": 1,
    "prev_price": "723.85",
    "mcapval": "455.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524075,
    "symbol": "ALBERTDAVD",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE155C01010",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "22:06 PM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "3.26 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/albert-david-876497-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Albert David Ltd Reports Strong Quarterly Turnaround Amid Mixed Long-Term Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/albert-david-ltd-reports-strong-quarterly-turnaround-amid-mixed-long-term-returns-4140838",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlbertDavidLtd_fintrenddot_4140838.png",
        "date": "2026-08-07 08:00:20",
        "description": "Albert David Ltd has delivered a markedly improved financial performance in the quarter ended June 2026, reversing previous flat trends with robust revenue growth and significant margin expansion. Despite lingering concerns over non-operating income dependency, the pharmaceutical micro-cap’s latest results signal a potential inflection point for investors."
      },
      {
        "title": "Albert David Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-is-rated-strong-sell-4131048",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlbertDavidLtd_mojoScore_4131048.png",
        "date": "2026-08-01 10:10:49",
        "description": "Albert David Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 20 July 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 01 August 2026, providing investors with the latest view of the company’s position in the market."
      },
      {
        "title": "Albert David Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-4111964",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlbertDavidLtd_mojoScore_4111964.png",
        "date": "2026-07-21 08:39:52",
        "description": "Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 20 Jul 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and unfavourable valuation metrics, signalling heightened risk for investors."
      },
      {
        "title": "Albert David Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-financials-4100292",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlbertDavidLtd_mojoScore_4100292.png",
        "date": "2026-07-14 08:47:37",
        "description": "Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 13 July 2026. This change is primarily driven by a shift in technical indicators, even as the company continues to grapple with flat financial performance and poor long-term growth metrics."
      },
      {
        "title": "Albert David Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-is-rated-sell-by-marketsmojo-4093348",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlbertDavidLtd_mojoScore_4093348.png",
        "date": "2026-07-08 10:11:28",
        "description": "Albert David Ltd is currently rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's present position as of 08 July 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Albert David Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-is-rated-sell-by-marketsmojo-4074856",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlbertDavidLtd_mojoScore_4074856.png",
        "date": "2026-06-27 10:10:48",
        "description": "Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Albert David Ltd Upgraded to Sell as Technicals Improve Amidst Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-upgraded-to-sell-as-technicals-improve-amidst-flat-financials-4055443",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlbertDavidLtd_mojoScore_4055443.png",
        "date": "2026-06-16 08:49:16",
        "description": "Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 15 June 2026. This change reflects nuanced shifts across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but slightly less negative outlook for investors."
      },
      {
        "title": "Albert David Ltd Downgraded to Strong Sell Amidst Deteriorating Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-downgraded-to-strong-sell-amidst-deteriorating-fundamentals-and-bearish-technicals-4040536",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlbertDavidLtd_mojoScore_4040536.png",
        "date": "2026-06-09 08:55:42",
        "description": "Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 8 June 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and unfavourable valuation metrics, signalling heightened risk for investors in the stock currently trading at ₹696.40."
      },
      {
        "title": "Albert David Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-is-rated-sell-4013491",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlbertDavidLtd_mojoScore_4013491.png",
        "date": "2026-05-26 10:10:29",
        "description": "Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 181,
    "sid": "876497",
    "stock_news_url": "https://www.marketsmojo.com/news/albert-david-876497"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "06-Aug-2026",
      "details": "Proceedings of 87th Annual General Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "06-Aug-2026",
      "details": "Intimation under Regulation 30 - Resignation of Senior Managerial Personnel",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 06.08.2026",
      "datetime": "06-Aug-2026",
      "details": "Outcome of Board Meeting dated 06.08.2026 regarding approval of Unaudited Financial Results for quarter ended 30th June 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Albert David Ltd has declared <strong>50%</strong> dividend, ex-date: 30 Jul 26",
          "dt": "2026-07-30",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Albert David Ltd Reports Strong Quarterly Turnaround Amid Mixed Long-Term Returns

2026-08-07 08:00:20

Albert David Ltd has delivered a markedly improved financial performance in the quarter ended June 2026, reversing previous flat trends with robust revenue growth and significant margin expansion. Despite lingering concerns over non-operating income dependency, the pharmaceutical micro-cap’s latest results signal a potential inflection point for investors.

Read full news article

Albert David Ltd is Rated Strong Sell

2026-08-01 10:10:49

Albert David Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 20 July 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 01 August 2026, providing investors with the latest view of the company’s position in the market.

Read full news article

Albert David Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-07-21 08:39:52

Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 20 Jul 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and unfavourable valuation metrics, signalling heightened risk for investors.

Read full news article

Albert David Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials

2026-07-14 08:47:37

Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 13 July 2026. This change is primarily driven by a shift in technical indicators, even as the company continues to grapple with flat financial performance and poor long-term growth metrics.

Read full news article

Albert David Ltd is Rated Sell by MarketsMOJO

2026-07-08 10:11:28

Albert David Ltd is currently rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's present position as of 08 July 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article

Albert David Ltd is Rated Sell by MarketsMOJO

2026-06-27 10:10:48

Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Albert David Ltd Upgraded to Sell as Technicals Improve Amidst Flat Financials

2026-06-16 08:49:16

Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 15 June 2026. This change reflects nuanced shifts across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but slightly less negative outlook for investors.

Read full news article

Albert David Ltd Downgraded to Strong Sell Amidst Deteriorating Fundamentals and Bearish Technicals

2026-06-09 08:55:42

Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 8 June 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and unfavourable valuation metrics, signalling heightened risk for investors in the stock currently trading at ₹696.40.

Read full news article

Albert David Ltd is Rated Sell

2026-05-26 10:10:29

Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News